News Archives - Page 169 of 1183 - BioHealth Innovation

Cursor and Stem Cell Therapy for NEC Dr David Hackam Maryland Stem Cell Research Fund YouTube

News

January 18, 2022

Stem Cell Therapy for NEC – Dr. David Hackam | Maryland Stem Cell Research Fund – YouTube

Dr. David Hackam and his lab are utilizing human stem cell technologies to tackle the leading cause of death and…

admin

Love0

News

January 18, 2022

NIH Technology Accelerator Challenge (NTAC) | National Institute of Biomedical Imaging and Bioengineering

Prize Competition for Maternal Health NIBIB launched the NIH Technology Accelerator Challenge (NTAC) series of prize competitions to stimulate the…

admin

Love0

News

January 18, 2022

Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development | Immunology | Frontiers

Monoclonal antibodies (mAbs) have proven effective for the treatment of ebolavirus infection in humans, with two mAb-based drugs Inmazeb™ and…

admin

Love0

News

January 18, 2022

JHU revises COVID-19 safety protocols ahead of spring semester | Hub

Johns Hopkins University is revising its safety protocols ahead of the start of the spring semester as it prepares to…

admin

Love0

https://en.wikipedia.org/wiki/Martine_Rothblatt

News

January 18, 2022

One Of America’s Richest Self-Made Women, Martine Rothblatt, Played Key Role In Week’s Historic Heart Transplant

When the University of Maryland Medical Center announced the first successful transplant of a heart that was grown in a…

admin

Love0

Surgeons at the University of Maryland Medical Center transplanted a genetically altered pig heart into David Bennett.Credit: University of Maryland School of Medicine

News

January 18, 2022

First pig-to-human heart transplant: what can scientists learn?

The first person to receive a transplanted heart from a genetically modified pig is doing well after the procedure last…

admin

Love0

News

January 18, 2022

Founder and Executive Chairman of Emergent BioSolutions Announces Retirement

GAITHERSBURG, Md., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Fuad El-Hibri, founder and…

admin

Love0

News

January 18, 2022

BioSpace: Cartesian Aims to Propel RNA Cell Therapy with Combinations

Published: Jan 07, 2022 By Gail Dutton Cartesian Therapeutics is developing non-permanent cell therapies that can be used soon…

admin

Love0

News

January 18, 2022

Institute for Bioscience and Biotechnology Research Receives $16.8M Investment from the National Institute of Standards and Technology

Fri, Jan 14, 2022 New Cooperative Agreement to Aid in the Development of Therapeutics and Vaccines, Improve Access to…

admin

Love0

Mouse neurons imaged using a method similar to one being developed as a high-throughput tool by a focused research organization. Credit: P. W. Tillberg et al./Nature Biotechnol.

News

January 18, 2022

Unblock research bottlenecks with non-profit start-ups

It takes more than a great idea to accomplish a great project. Our research and experience have convinced us that…

admin

Love0

News

Stem Cell Therapy for NEC – Dr. David Hackam | Maryland Stem Cell Research Fund – YouTube

NIH Technology Accelerator Challenge (NTAC) | National Institute of Biomedical Imaging and Bioengineering

Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development | Immunology | Frontiers

JHU revises COVID-19 safety protocols ahead of spring semester | Hub

One Of America’s Richest Self-Made Women, Martine Rothblatt, Played Key Role In Week’s Historic Heart Transplant

First pig-to-human heart transplant: what can scientists learn?

Founder and Executive Chairman of Emergent BioSolutions Announces Retirement

BioSpace: Cartesian Aims to Propel RNA Cell Therapy with Combinations

Institute for Bioscience and Biotechnology Research Receives $16.8M Investment from the National Institute of Standards and Technology

Unblock research bottlenecks with non-profit start-ups

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search